We are live on ! Find out more
VA

Vident Advisory Portfolio holdings

AUM $11.7B
1-Year Est. Return 37.32%
This Fund
S&P 500
This Quarter Est. Return
+9.55%
1 Year Est. Return
+37.32%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.8B
AUM Growth
+$821M
Cap. Flow
+$504M
Cap. Flow %
10.5%
Top 10 Hldgs %
11.73%
Holding
1,467
New
156
Increased
744
Reduced
407
Closed
145

Top Buys

Rank Stock Value
1
HON icon
Honeywell
HON
+$22.8M
2
AMZN icon
Amazon
AMZN
+$22.6M
3
BKNG icon
Booking.com
BKNG
+$21.4M
4
TXT icon
Textron
TXT
+$19M
5
EPD icon
Enterprise Products Partners
EPD
+$18.8M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$41.4M
2
HD icon
Home Depot
HD
+$34M
3
ABT icon
Abbott
ABT
+$20.7M
4
AMAT icon
Applied Materials
AMAT
+$20.7M
5
LRCX icon
Lam Research
LRCX
+$20.4M

Sector Composition

Rank Sector Weight
1 Technology 23.28%
2 Healthcare 13.79%
3 Industrials 13.1%
4 Financials 10.13%
5 Consumer Discretionary 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNXC icon
1076
Concentrix
CNXC
$1.48B
$276K 0.01%
4,170
-513
-11% -$41.7K
GATX icon
1077
GATX Corp
GATX
$6.52B
$276K 0.01%
2,056
+105
+5% +$13.2K
LEU icon
1078
Centrus Energy
LEU
$3.34B
$276K 0.01%
+6,635
New +$304K
MKTX icon
1079
MarketAxess Holdings
MKTX
$4.2B
$275K 0.01%
+1,256
New +$297K
CIEN icon
1080
Ciena
CIEN
$52.2B
$275K 0.01%
5,556
-206
-4% -$10.9K
AVT icon
1081
Avnet
AVT
$7.06B
$275K 0.01%
5,540
+378
+7% +$17.7K
SRPT icon
1082
Sarepta Therapeutics
SRPT
$1.72B
$274K 0.01%
2,119
-180
-8% -$22K
FDMT icon
1083
4D Molecular Therapeutics
FDMT
$534M
$274K 0.01%
+8,600
New +$219K
VOOG icon
1084
Vanguard S&P 500 Growth ETF
VOOG
$25.2B
$273K 0.01%
5,370
PRDO icon
1085
Perdoceo Education
PRDO
$1.98B
$273K 0.01%
15,526
+4,059
+35% +$71.7K
RNW icon
1086
ReNew
RNW
$2.23B
$273K 0.01%
45,433
-6,526
-13% -$43K
SCHL icon
1087
Scholastic
SCHL
$759M
$272K 0.01%
+7,210
New +$277K
SANA icon
1088
Sana Biotechnology
SANA
$904M
$271K 0.01%
27,059
+1,889
+8% +$14.2K
EVGO icon
1089
EVgo
EVGO
$207M
$270K 0.01%
107,660
+42,803
+66% +$111K
PPL
1090
PPL Corp
PPL
$27.1B
$269K 0.01%
9,756
+1,359
+16% +$36.2K
ASR icon
1091
Grupo Aeroportuario del Sureste
ASR
$8.13B
$267K 0.01%
839
+58
+7% +$17.1K
DOCU
1092
DocuSign
DOCU
$10.3B
$267K 0.01%
4,485
-39
-0.9% -$2.2K
AN icon
1093
AutoNation
AN
$7.1B
$267K 0.01%
1,611
-3,071
-66% -$452K
JAAA icon
1094
Janus Henderson AAA CLO ETF
JAAA
$29.1B
$266K 0.01%
+5,247
New +$265K
MYGN icon
1095
Myriad Genetics
MYGN
$523M
$265K 0.01%
12,451
-351
-3% -$7.54K
SNPS icon
1096
Synopsys
SNPS
$74.7B
$265K 0.01%
463
-19,869
-98% -$10.9M
QGEN icon
1097
Qiagen
QGEN
$8.54B
$261K 0.01%
5,905
-261
-4% -$11.9K
ITCI
1098
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$261K 0.01%
3,772
+582
+18% +$40K
NDAQ icon
1099
Nasdaq
NDAQ
$51.9B
$260K 0.01%
4,113
-224,644
-98% -$13M
HXL icon
1100
Hexcel
HXL
$8.12B
$259K 0.01%
+3,553
New +$256K

Similar funds

Vident Advisory's Q1 2024 Portfolio in Review

As of Q1 2024, Vident Advisory held 1,467 positions worth $4.8B, up 21% from $3.98B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Vident Advisory deployed $504M of net new capital in Q1 2024, opening 156 new positions and adding to 744 existing holdings. Its largest new stake was Enterprise Products Partners: 685,949 shares worth $20M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Broadcom, an estimated $41.4M trimmed.

  • Vident Advisory's largest Q1 2024 buy was Enterprise Products Partners: 685,949 shares worth $20M.
  • Vident Advisory added most to Honeywell in Q1 2024, an estimated $22.8M increase.
  • Vident Advisory's biggest Q1 2024 reduction was Broadcom, cutting an estimated $41.4M.
  • Vident Advisory fully exited Sysco in Q1 2024, selling an estimated $13.3M.
  • Vident Advisory's ten largest holdings make up 12% of its $4.8B portfolio in Q1 2024.
  • Vident Advisory opened 156 new positions and closed 145 in Q1 2024.
  • Vident Advisory's portfolio value rose 21% quarter-over-quarter to $4.8B.

Based on Vident Advisory's 13F filing for Q1 2024, filed 14 May 2024.